$-0.26
(Market cap
$2,767 Mln
Revenue (TTM)
$251 Mln
P/E Ratio
--
P/B Ratio
10.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
4083.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.7
-
Face value
--
-
Shares outstanding
53,761,513
10 Years Aggregate
CFO
$-126.49 Mln
EBITDA
$-161.32 Mln
Net Profit
$-209.36 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Axogen Inc (AXGN)
| 57.3 | 25.1 | 29.1 | 218.9 | 101.0 | 25.1 | 19.2 |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Axogen Inc (AXGN)
| 98.6 | 139.6 | -31.6 | 6.5 | -47.7 | 0.1 | -12.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Axogen Inc (AXGN)
|
51.5 | 2,767.1 | 251.2 | -33.6 | -7.7 | -17.4 | -- | 10.8 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.5 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Axogen Inc (AXGN)
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft... intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida. Read more
-
Chairman, President & CEO
Ms. Karen Zaderej
-
Chairman, President & CEO
Ms. Karen Zaderej
-
Headquarters
Alachua, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Axogen Inc (AXGN)
What is the current share price of Axogen Inc (AXGN) Today?
The share price of Axogen Inc (AXGN) is $51.47 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Axogen Inc (AXGN) has given a return of 100.98% in the last 3 years.
What is the current PB & PE ratio of Axogen Inc (AXGN)?
Since, TTM earnings of Axogen Inc (AXGN) is negative, P/E ratio is not available.
The P/B ratio of Axogen Inc (AXGN) is 10.85 times as on 28-Aug-2026, a 186 premium to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-97.82 |
11.92 |
2024 |
-79.50 |
7.62 |
2023 |
-13.54 |
3.07 |
2022 |
-14.59 |
4.18 |
2021 |
-14.40 |
3.45 |
What is the 52 Week High and Low of Axogen Inc (AXGN)?
The 52-week high and low of Axogen Inc (AXGN) are Rs 52.91 and Rs 15.24 as of 31-Aug-2026.
What is the market cap of Axogen Inc (AXGN)?
Axogen Inc (AXGN) has a market capitalisation of $ 2,767 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Axogen Inc (AXGN)?
Before investing in Axogen Inc (AXGN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.